HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amelioration of high-fat diet-induced obesity and its associated complications by a myricetin derivative-rich fraction from Syzygium malaccense in C57BL/6J mice.

Abstract
Obesity is a driving factor in the onset of metabolic disorders. This study aims to investigate the effects of the myricetin derivative-rich fraction (MD) from Syzygium malaccense leaf extract on high-fat diet (HFD)-induced obesity and its associated complications and its influence on uncoupling protein-1 (UCP-1) and gut microbiota in C57BL/6J mice. Mice were randomly assigned into four groups (n = 6) and given a normal diet (ND) or high-fat diet (HFD) for 10 weeks to induce obesity. The HFD groups (continued with HFD) were administered 50 mg kg-1 MD (treatment), 50 mg kg-1 metformin (positive control) and normal saline (HFD and ND controls) daily for four weeks via oral gavage. The ten-week HFD-feeding resulted in hyperglycemia and elevated urinary oxidative indices. The subsequent MD administration caused significant weight reduction without appetite suppression and amelioration of insulin resistance, steatosis and dyslipidemia. Besides, MD significantly reduced lipid hydroperoxides and protein carbonyls in tissue homogenates and urine and elevated Trolox equivalent antioxidant capacity (TEAC), ferric reducing antioxidant power (FRAP) and reduced glutathione (GSH) and thus, alleviated oxidative stress. The weight reduction was correlated with downregulation of inflammatory markers and the increased UCP-1 level, suggesting weight loss plausibly through thermogenesis. The Akkermansia genus (reflects improved metabolic status) in the HFD50 group was more abundant than that in the HFD group while the non-enzymatic antioxidant markers were strongly associated with UCP-1. In conclusion, MD ameliorates obesity and its related complications possibly via the upregulation of UCP-1 and increased abundance of Akkermansia genus and is promising as a therapeutic agent in the treatment of obesity and its associated metabolic disorders.
AuthorsDevi Nallappan, Kek Heng Chua, Kien Chai Ong, Chun Wie Chong, Cindy Shuan Ju Teh, Uma Devi Palanisamy, Umah Rani Kuppusamy
JournalFood & function (Food Funct) Vol. 12 Issue 13 Pg. 5876-5891 (Jul 05 2021) ISSN: 2042-650X [Electronic] England
PMID34019055 (Publication Type: Journal Article)
Chemical References
  • Antioxidants
  • Blood Glucose
  • Flavonoids
  • Insulin
  • myricetin
  • Glutathione
Topics
  • Animals
  • Antioxidants
  • Blood Glucose
  • Diet, High-Fat (adverse effects)
  • Dyslipidemias
  • Energy Intake
  • Flavonoids (chemistry, pharmacology)
  • Gastrointestinal Microbiome (drug effects)
  • Glutathione (metabolism)
  • Insulin (blood)
  • Insulin Resistance
  • Male
  • Metabolic Diseases
  • Mice
  • Mice, Inbred C57BL
  • Obesity (chemically induced, metabolism)
  • Syzygium (chemistry)
  • Thermogenesis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: